Patent 12070466 was granted and assigned to Sydnexis on August, 2024 by the United States Patent and Trademark Office.
Provided herein is an ophthalmic composition formulated in deuterated water. Also disclosed herein are methods of treating, ameliorating, or reducing ophthalmic conditions or diseases by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.